Paul Lock – Chairman & Managing Director – Pan Asia Metals (PAM) is a minerals exploration and development company with tungsten and lithium projects located in southern Thailand.
Copyright 2023 – Finance News Network
Source: Finance News Network
06 Sep 2021 - Rural Funds Group (ASX:RFF) General Manager - Investor Relations and Marketing James Powell presents on the group's FY21 results.
Read More12 Oct 2023 - QX Resources (ASX:QXR) CEO Steve Promnitz discusses recent funding success and promising prospects for Liberty Lithium Brine Project.
Read More30 Jul 2021 - Novatti Group Limited (ASX:NOV) CEO, Peter Cook, provides an update on activities from the company's June quarter, discussing growth in platforms and infrastructure and the recent capital raise.
Read More16 May 2023 - ABx Group Limited (ASX:ABX) CEO and Managing Director Dr Mark Cooksey discusses the advantages of ionic clay rare earths deposits, the company's exploration program, its plays for a scoping study and a pilot plant, and its new process to develop fluorine from aluminium smelting waste.
Read More28 Feb 2022 - BHP Group Limited (ASX:BHP) CEO Mike Henry and CFO David Lamont provide a shareholder update with Gabrielle Notley, Head of Corporate Communications.
Read More06 Sep 2021 - Paragon Care Limited (ASX:PGC) CEO Phil Nicholl provides an update on FY21 results, which reported growth in all key financial metrics and the recommencement of dividends.
Read More20 Mar 2023 - Magontec Limited (ASX:MGL) Executive Chairman and CEO Nicholas Andrews discusses the magnesium industry, drivers of demand, China, supply chains into the US and Europe, and recent financial results.
Read More29 Mar 2021 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt talks about the Bristol Myers Squibb trial evaluating Anti-LAG-3 Antibody Relatlimab and Opdivo (nivolumab) in patients with previously untreated metastatic or unresectable melanoma, meeting its primary endpoint of progression-free survival and what it means for Immutep.
Read More24 Jun 2020 - Immutep (ASX:IMM) CEO, Marc Voigt provides an update on its clinical trials including metastatic breast cancer (MBC), its global leadership under Chief Scientist and Medical Officer, Professor Frederic Triebel, and the growing interest by big pharma in immuno-therapies.
Read More23 Sep 2024 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses the company's latest results in head and neck cancer.
Read More
